– CANADA, Toronto – Synaptive Medical, a leading Canadian medical device and technology company, announced today the appointment of veteran healthcare executive and current chairman of the board Peter Wehrly as chief executive officer. Cameron Piron will continue to serve as president and assume the new role of chief strategy officer.

As CEO, Peter’s primary focus will be on business operations, commercial execution, product development and execution to strategy. Cameron, as president and chief strategy officer, will focus on Synaptive’s long-term vision, strategic relationships, collaboration with employees and clients, investor relations and advanced research. Together, they will provide visionary and strategic leadership, as well as operational excellence in product development and commercialization.

“Peter’s addition to the executive leadership team will enable Synaptive to grow and continue its current success,” said Cameron Piron. “Hiring a CEO has been part of Synaptive’s long-term plan to scale and grow as a medical device and technology company. I am excited to continue to work with Peter in his new role to lead Synaptive as we continue our momentum towards executing product development milestones, achieving financial goals and ensuring we have a work environment that fosters high employee engagement.”

Peter joins Synaptive Medical after a notable career as a health technology leader. As a global executive with over 20 years of experience, Peter has a history of taking organizations in the medical sector to higher levels of performance with a clear focus on executing strategies that deliver value for customers and investors.

“Having served as chairman of the board and now as CEO, I’m proud to be a part of the leadership team that is propelling Synaptive Medical into its place as Canada’s medical device leader,” said Peter Wehrly. “I look forward to working alongside Cameron and our talented employees as we continue to build the Connected OR of the future.”

Synaptive was formed in 2012, with the vision of disrupting silos in the operating room and across traditional hospitals. With innovative products, a passion for patient care and commitment to reimagining the operating room and the integration of patient data, Synaptive is poised to continue to scale-up and play a leadership role in the medical device industry. The company employs over 300 people worldwide and counts General Atlantic among its investors.

About Synaptive Medical Inc.

Synaptive Medical Inc., a Toronto-based medical device and technology company, collaborates with leading clinicians and healthcare systems to integrate revolutionary products and services that cross traditional barriers and information silos in and beyond the operating room. Privately funded and based in Toronto, Synaptive’s BrightMatter™ solution — which includes surgical planning and navigation, robotic digital microscopy and informatics — gives clinicians the right information where and when they need it to ensure the best possible outcomes for their patients.

For more information : http://www.synaptivemedical.com

- DisclaimerNews, data and statement included in this release are intended exclusively for information purposes. Product and brand names used in this release maybe trademarks or registered trade marks of their respective owners. Talent4Boards accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the adequacy or accuracy of this release. No data or statement in this release should be considered a recommendation for the purchase, retention or sale of the securities referred to herein.

Talent4Boards Team

here the original post =>

Comments are closed.